FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2024734036> ?p ?o ?g. }

• W2024734036 endingPage "89" @default.
• W2024734036 startingPage "83" @default.
• W2024734036 abstract "Natural killer (NK) cells and NK cell activity were determined in three groups (newly diagnosed [n = 21], on therapy [n = 21], and off therapy [n = 18]) of children with various types of malignant solid tumors and in a control group (n = 26) by means of Leu-7 and Leu-11b monoclonal antibodies and a 4-hour 51Cr-release assay, respectively. The erythroleukemia cell line K562 was used as a target cell. The newly diagnosed group included eight patients with localized disease (Stage I-II), ten with bulky but nonmetastatic disease (Stage III), and three with metastases (Stage IV). The mean percent of NK cell activity in the newly diagnosed group was significantly higher than that of the control group. Children with Stage III tumors at diagnosis had higher mean NK cell function than those with Stage I-II and Stage IV. On therapy patients had significantly fewer NK cells and lower NK cell cytotoxicity than those in the other groups studied. We also studied the following: (1) the in vitro effect of recombinant interferon-alpha (rIFN-alpha) and recombinant interleukin-2 (rIL-2) on NK cell function of peripheral blood lymphocytes (PBL) from children with solid malignancies; and (2) the susceptibility of neuroblastoma-derived (CHP-126 and SKNSH) and rhabdomyosarcoma-derived (A-204) cell lines to NK cell lysis. Both rIFN-alpha and rIL-2 enhanced NK cell activity of PBL from children with malignancies and healthy children against K562 and solid tumor cell lines. The enhancing effect or rIL-2 was greater than that of rIFN-alpha. CHP-126 and SKNSH cell lines were susceptible to NK cell lysis mediated by the PBL of children with neuroblastoma and the control group. The A-204 cell line was less sensitive than K562 to NK cell cytotoxicity. Our results suggest a potential therapeutic role for both cytokines in the treatment of malignant solid tumors of childhood." @default.
• W2024734036 created "2016-06-24" @default.
• W2024734036 creator A5007906999 @default.
• W2024734036 creator A5008424253 @default.
• W2024734036 creator A5015247283 @default.
• W2024734036 creator A5032647184 @default.
• W2024734036 creator A5042237180 @default.
• W2024734036 creator A5042585088 @default.
• W2024734036 creator A5053707957 @default.
• W2024734036 creator A5072328892 @default.
• W2024734036 date "1989-01-01" @default.
• W2024734036 modified "2023-10-16" @default.
• W2024734036 title "Natural killer cells in children with malignant solid tumors. Effect of recombinant interferon-α and interleukin-2 on natural killer cell function against tumor cell lines" @default.
• W2024734036 cites W1980849025 @default.
• W2024734036 cites W1991360369 @default.
• W2024734036 cites W2024049166 @default.
• W2024734036 cites W2055022264 @default.
• W2024734036 cites W2066407805 @default.
• W2024734036 cites W2104417744 @default.
• W2024734036 cites W2409360224 @default.
• W2024734036 cites W2486998585 @default.
• W2024734036 doi "https://doi.org/10.1002/1097-0142(19890101)63:1<83::aid-cncr2820630114>3.0.co;2-a" @default.
• W2024734036 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/2783377" @default.
• W2024734036 hasPublicationYear "1989" @default.
• W2024734036 type Work @default.
• W2024734036 sameAs 2024734036 @default.
• W2024734036 citedByCount "18" @default.
• W2024734036 countsByYear W20247340362012 @default.
• W2024734036 countsByYear W20247340362014 @default.
• W2024734036 countsByYear W20247340362016 @default.
• W2024734036 countsByYear W20247340362020 @default.
• W2024734036 countsByYear W20247340362023 @default.
• W2024734036 crossrefType "journal-article" @default.
• W2024734036 hasAuthorship W2024734036A5007906999 @default.
• W2024734036 hasAuthorship W2024734036A5008424253 @default.
• W2024734036 hasAuthorship W2024734036A5015247283 @default.
• W2024734036 hasAuthorship W2024734036A5032647184 @default.
• W2024734036 hasAuthorship W2024734036A5042237180 @default.
• W2024734036 hasAuthorship W2024734036A5042585088 @default.
• W2024734036 hasAuthorship W2024734036A5053707957 @default.
• W2024734036 hasAuthorship W2024734036A5072328892 @default.
• W2024734036 hasConcept C109316439 @default.
• W2024734036 hasConcept C129374314 @default.
• W2024734036 hasConcept C142724271 @default.
• W2024734036 hasConcept C1491633281 @default.
• W2024734036 hasConcept C171122931 @default.
• W2024734036 hasConcept C202751555 @default.
• W2024734036 hasConcept C203014093 @default.
• W2024734036 hasConcept C2776090121 @default.
• W2024734036 hasConcept C2777371288 @default.
• W2024734036 hasConcept C2777701055 @default.
• W2024734036 hasConcept C2778102761 @default.
• W2024734036 hasConcept C2778256501 @default.
• W2024734036 hasConcept C2778461978 @default.
• W2024734036 hasConcept C2778690821 @default.
• W2024734036 hasConcept C2780844630 @default.
• W2024734036 hasConcept C2781228144 @default.
• W2024734036 hasConcept C28651165 @default.
• W2024734036 hasConcept C502942594 @default.
• W2024734036 hasConcept C54355233 @default.
• W2024734036 hasConcept C55493867 @default.
• W2024734036 hasConcept C71924100 @default.
• W2024734036 hasConcept C81885089 @default.
• W2024734036 hasConcept C86803240 @default.
• W2024734036 hasConcept C8891405 @default.
• W2024734036 hasConceptScore W2024734036C109316439 @default.
• W2024734036 hasConceptScore W2024734036C129374314 @default.
• W2024734036 hasConceptScore W2024734036C142724271 @default.
• W2024734036 hasConceptScore W2024734036C1491633281 @default.
• W2024734036 hasConceptScore W2024734036C171122931 @default.
• W2024734036 hasConceptScore W2024734036C202751555 @default.
• W2024734036 hasConceptScore W2024734036C203014093 @default.
• W2024734036 hasConceptScore W2024734036C2776090121 @default.
• W2024734036 hasConceptScore W2024734036C2777371288 @default.
• W2024734036 hasConceptScore W2024734036C2777701055 @default.
• W2024734036 hasConceptScore W2024734036C2778102761 @default.
• W2024734036 hasConceptScore W2024734036C2778256501 @default.
• W2024734036 hasConceptScore W2024734036C2778461978 @default.
• W2024734036 hasConceptScore W2024734036C2778690821 @default.
• W2024734036 hasConceptScore W2024734036C2780844630 @default.
• W2024734036 hasConceptScore W2024734036C2781228144 @default.
• W2024734036 hasConceptScore W2024734036C28651165 @default.
• W2024734036 hasConceptScore W2024734036C502942594 @default.
• W2024734036 hasConceptScore W2024734036C54355233 @default.
• W2024734036 hasConceptScore W2024734036C55493867 @default.
• W2024734036 hasConceptScore W2024734036C71924100 @default.
• W2024734036 hasConceptScore W2024734036C81885089 @default.
• W2024734036 hasConceptScore W2024734036C86803240 @default.
• W2024734036 hasConceptScore W2024734036C8891405 @default.
• W2024734036 hasIssue "1" @default.
• W2024734036 hasLocation W20247340361 @default.
• W2024734036 hasLocation W20247340362 @default.
• W2024734036 hasOpenAccess W2024734036 @default.
• W2024734036 hasPrimaryLocation W20247340361 @default.
• W2024734036 hasRelatedWork W1966264110 @default.
• W2024734036 hasRelatedWork W1972290415 @default.
• W2024734036 hasRelatedWork W1982937478 @default.
• W2024734036 hasRelatedWork W2000126505 @default.

• next